The scope of EU GMP Annex 1 names creams, ointments and certain liquids. Many semi-solids plants have never opened it.
The 2022 revision is written for sterile products, but its scope section says some of its principles may be used for products that are not sterile, where control of microbial, particulate and endotoxin contamination still matters. It lists the contamination control strategy, premises design, cleanroom classification, qualification, monitoring and gowning among them, and gives examples: certain liquids, creams, ointments and low-bioburden biological intermediates.
"May be used" is permissive wording. Even so, an inspector who finds a cream filling room with no documented reasoning for its grade, its pressure regime or its monitoring points will ask what the site relied on instead. A plant that can point to its own CCS, built on the same logic, has an answer. "We are non-sterile" is only a scope argument.
The work is modest: one document that ties the room grade, airflow, material and personnel flows, the water system and the monitoring plan to the product risk. Most semi-solids plants already hold the pieces, scattered across SOPs and the HVAC design report.
Humiley uses the Annex 1 CCS as the organizing document on Life Sciences projects, so that airflow, flows, barriers, utilities, monitoring and qualification read as one argument.
Industries




